CTLA4 and neoplasm: In addition, the CTLA-4 antibody, which combines with dendritic cells, can decrease the level of CD4+ regulatory T cells (Tregs) and increase the concentration of cytotoxic T cells in metastatic OS mice for tumor suppression (167, 168).